First reported 10 hours ago -
Updated 10 hours ago -
Amgen Inc. (AMGN) , the world’s largestbiotechnology company by sales, reported first-quarter revenuebelow analysts’ estimates on lower-than-expected demand of itstop drug, Enbrel
.Quarterly sales increased 6.6 percent to $4.52 billioncompared with a year ...
[Published Bloomberg - 10 hours ago]